REZIPRES is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eton Pharmaceuticals, Inc.. The primary component is Ephedrine Hydrochloride.
| Product ID | 71863-210_2ed4c742-ab6c-484c-8243-0283aad354cd |
| NDC | 71863-210 |
| Product Type | Human Prescription Drug |
| Proprietary Name | REZIPRES |
| Generic Name | Ephedrine Hydrochloride |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-06-14 |
| Marketing Category | NDA / |
| Application Number | NDA213536 |
| Labeler Name | Eton Pharmaceuticals, Inc. |
| Substance Name | EPHEDRINE HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/mL |
| Pharm Classes | alpha-Adrenergic Agonist [EPC],Adrenergic alpha-Agonists [MoA],beta-Adrenergic Agonist [EPC],Adrenergic beta-Agonists [MoA],Norepinephrine Releasing Agent [EPC],Increased Norepinephrine Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-10-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 39822-1410 | REZIPRES | Ephedrine hydrochloride |
| 71863-210 | REZIPRES | Ephedrine hydrochloride |
| 71863-211 | REZIPRES | Ephedrine hydrochloride |
| 71863-212 | REZIPRES | Ephedrine hydrochloride |
| 0363-9812 | Ephedrine Hydrochloride | Ephedrine Hydrochloride |
| 80070-600 | Primatene | EPHEDRINE HYDROCHLORIDE |
| 71952-030 | Rinosan MINT Nasal Decongestant | EPHEDRINE HYDROCHLORIDE |
| 73061-001 | Rinosan Mint Nasal Decongestant | EPHEDRINE HYDROCHLORIDE |
| 71952-040 | Rinosan PROPO Nasal Decongestant | EPHEDRINE HYDROCHLORIDE |
| 73061-002 | Rinosan Propo Nasal Decongestant | EPHEDRINE HYDROCHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() REZIPRES 90060774 not registered Live/Pending |
Eton Pharmaceuticals, Inc. 2020-07-19 |